Get in touch

Submit

Thank you

Pharmaceutical products can often attract patent protection.  This affords the owner a monopoly in that product; however, the monopoly will only last a fixed period, after which it is open season for competitors.  Choosing a strong, resilient brand name will help foster brand loyalty and encourage customers to continue purchasing your product even when other (potentially cheaper) products have become available.  Obtaining a trade mark registration for your brand name allows you to stop other businesses cashing in on your brand loyalty/success.  It also affords protection against inferior products tainting your hard-earned brand recognition.

 

Pharmaceutical trade marks require regulatory approval.  In the UK, the appropriate body is the Medicines and Healthcare Products Regulatory Agency (MHRA).  The MHRA will reject a proposed pharmaceutical brand name if they believe that: (i) consumers will confuse the chosen name with the name of an existing medicine; (ii) the chosen name is misleading; or (iii) the chosen name is considered unsafe.  Regulatory approval is required before a pharmaceutical product can be sold under the chosen name.

 

The MHRA’s assessment of the trade mark is entirely separate to the assessment undertaken by the UK Intellectual Property Office (UKIPO) if/when a UK trade mark application is filed.  The UKIPO will reject a trade mark application if it considers the mark descriptive or non-distinctive (e.g. “strong medicine” or “cough mixture plus”) – such terms are to be kept free for all to use.  If the UKIPO decides that the brand name meets this threshold it will publish it for opposition purposes – this is where an objection can be brought by the owner of an earlier conflicting right.  It is strongly advisable to conduct a trade mark search prior to selecting a brand name so that you have an idea of the risk profile of the mark and the likelihood of a third party objection being raised. 

 

A trade mark registration is generally valid for 10 years and can be renewed for successive 10 year period, potentially indefinitely.  However, bear in mind that ownership of a trade mark registration does not give you the right to sell a pharmaceutical product under the registered name, regulatory approval is required for that.

 

Recommendations in light of the above:

  • Kick-off the naming process as early as possible
  • Pick distinctive, memorable trade marks, not ones that describe your products (or characteristics)
  • Consider multiple potential names, or at least have some fall-back alternatives in mind
  • Conduct searches of the MHRA and trade mark registers at an early stage
  • Subject to the results of the searches, apply to register your trade marks

 

MoreThe Importance of Branding in Life Sciences, Healthcare and Precision Medicine

30.06.2021

The Importance of Branding in Life Sciences, Healthcare and Precision Medicine

Branding has a very important role to play in any industry. However, it is crucial in the fields of life sciences, pharmaceuticals, healthcare and also precision medicine which, by its very nature, is personal. For this reason, brand names in these areas should resonate with people (think ‘hearts and minds’).

MoreDual filing, cloned rights and new guidelines: Brexit’s impact on Trade Marks, Designs and IP Management

19.08.2021

Dual filing, cloned rights and new guidelines: Brexit’s impact on Trade Marks, Designs and IP Management

Britain leaving the European Union has changed how Trade Marks and Design Rights are filed and managed. According to Kane Ridley, Keltie’s Head of Trade Mark Support, now is the time for everyone to review their IP portfolios to avoid lost UK rights and future complications.

Get in touch

Submit

Thank you